0001179110-16-028966.txt : 20160823
0001179110-16-028966.hdr.sgml : 20160823
20160823192317
ACCESSION NUMBER: 0001179110-16-028966
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160819
FILED AS OF DATE: 20160823
DATE AS OF CHANGE: 20160823
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAUMANN BRETT K
CENTRAL INDEX KEY: 0001607733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 161848095
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2016-08-19
0
0001583107
Theravance Biopharma, Inc.
TBPH
0001607733
HAUMANN BRETT K
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP Clin Dev & Chief Med Ofc
Ordinary Shares
2016-08-19
4
S
0
9509
27.97
D
197391
D
Ordinary Shares
2016-08-20
4
F
0
4607
27.89
D
192784
D
This transaction was executed in multiple trades at prices from $27.85 to $28.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Brett A. Grimaud, Attorney-in-Fact
2016-08-23